SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

11 Oct 2016 07:00

RNS Number : 1617M
Victrex PLC
11 October 2016
 
 

 

 

 

11 October 2016

Victrex plc: Full year and pre-close trading update

'Improved second half; good finish to 2016'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its full year and pre-close trading update for the financial year ended 30 September 2016, ahead of its preliminary results on 6 December 2016.

In line with expectations, Victrex delivered an improved performance in the second half and a good finish to 2016.

The core business was in growth, with Aerospace and Automotive performing well, and a more stable performance in Oil & Gas during the second half. Sales volumes for the large Consumer Electronics business were delivered on plan during Q4, with overall second half volumes more than double those in the first half. Q4, overall, saw a good performance with Group revenue up 8% to £73.7m (Q4 2015: £68.0m) and Q4 Group sales volume up 9% to 1,216 tonnes (Q4 2015: 1,119 tonnes).

Despite a positive finish to 2016, full year Group revenue declined by 4% to £252.3m (FY2015: £263.5m), reflecting the year on year fall in Consumer Electronics volumes, which were more than 30% down. Full year Group sales volume was down 6% at 3,952 tonnes (FY 2015: 4,217 tonnes).

Medical revenue (Invibio) for the full year of £50.8m (FY 2015: £50.5m) reflects a stable Spine market in the US. Growth outside of the US, in emerging markets, remains positive.

Our mega-programmes continue to make progress, with the Magma Oil & Gas project delivering first meaningful revenues of over £1m in FY16. Incremental investment opportunities aligned to our mega-programmes are also being progressed, which would further support delivery of the Group's downstream strategy and growth pipeline.

 

Outlook

 

As we start our new financial year, our core business remains robust. However, we remain mindful, as previously communicated, that our early planning assumption suggests Consumer Electronics volumes will be significantly lower in 2017, compared to 2016. This would also impact our operating leverage.

 

Whilst we will continue to invest in our 'front end' commercial, marketing and technical functions, to help drive adoption of our mega-programmes, we will also further enhance our ongoing focus on cost efficiency opportunities over the coming year.

 

With a differentiated strategy, a strong pipeline and a highly cash generative business model, Victrex remains in a good position to drive shareholder value for the medium to longer term.

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Teneo Blue Rubicon:

Charles Armitstead +44 (0) 207 260 2700

 

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the Automotive, Aerospace, Energy, Electronics and Medical markets. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we deliver leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGBUUUPQGQU
Date   Source Headline
20th May 20147:00 amRNSHalf Yearly Report
19th May 201411:57 amRNSDirector/PDMR Shareholding
30th Apr 20143:16 pmRNSTotal Voting Rights
17th Apr 20142:01 pmRNSDirector/PDMR Shareholding
10th Apr 20142:49 pmRNSHolding(s) in Company
8th Apr 20147:00 amRNSTrading Statement
3rd Apr 20141:33 pmRNSHolding(s) in Company
31st Mar 20144:25 pmRNSTotal Voting Rights
18th Mar 20144:29 pmRNSDirector/PDMR Shareholding
12th Mar 20143:08 pmRNSHolding(s) in Company
3rd Mar 201410:18 amRNSHolding(s) in Company
28th Feb 20142:00 pmRNSTotal Voting Rights
19th Feb 20145:04 pmRNSDirector/PDMR Shareholding
18th Feb 201412:01 pmRNSDirector/PDMR Shareholding
4th Feb 20142:17 pmRNSResult of AGM
4th Feb 20147:00 amRNSAGM and Q1 Interim Management Statement
31st Jan 20143:30 pmRNSDirectorate Change
31st Jan 20149:00 amRNSTotal Voting Rights
17th Jan 201410:07 amRNSDirector/PDMR Shareholding
15th Jan 20144:42 pmRNSHolding(s) in Company
14th Jan 20143:06 pmRNSDirector/PDMR Shareholding
2nd Jan 201411:37 amRNSAnnual Financial Report
31st Dec 20137:00 amRNSTotal Voting Rights
17th Dec 20135:17 pmRNSDirector/PDMR Shareholding
17th Dec 20134:47 pmRNSDirector/PDMR Shareholding
17th Dec 201311:36 amRNSDirector/PDMR Shareholding
13th Dec 20133:14 pmRNSHolding(s) in Company
10th Dec 20137:00 amRNSFinal Results
2nd Dec 20134:19 pmRNSBlocklisting Interim Review
29th Nov 20138:39 amRNSTotal Voting Rights
19th Nov 20132:16 pmRNSDirector/PDMR Shareholding
13th Nov 20133:33 pmRNSDirector Declaration
7th Nov 20137:00 amRNSDirectorate Change
31st Oct 20132:47 pmRNSTotal Voting Rights
25th Oct 201311:46 amRNSHolding(s) in Company
17th Oct 20132:31 pmRNSDirector/PDMR Shareholding
14th Oct 20133:51 pmRNSHolding(s) in Company
14th Oct 20133:48 pmRNSHolding(s) in Company
10th Oct 20137:00 amRNSInvestor Day
8th Oct 20137:00 amRNSTrading Statement
1st Oct 20134:31 pmRNSHolding(s) in Company
30th Sep 20132:56 pmRNSTotal Voting Rights
17th Sep 20133:35 pmRNSDirector/PDMR Shareholding
11th Sep 20133:45 pmRNSHolding(s) in Company
4th Sep 20138:42 amRNSDirector Declaration
30th Aug 20131:53 pmRNSHolding(s) in Company
30th Aug 20138:33 amRNSTotal Voting Rights
19th Aug 20134:07 pmRNSDirector/PDMR Shareholding
2nd Aug 20138:48 amRNSHolding(s) in Company
29th Jul 20137:56 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.